Pathway Genomics to Offer BRCA Test

Pathway Genomics announced over the weekend that it intends to begin offering the BRCA genetic tests. These tests were once the sole territory of Myriad Genetics until the Supreme Court overturned the company’s patents on the BRCA genes on June 14.
Businesswire